T-cell chauvinists versus antibody advocates - Can't we all just get along? Journal Article


Author: Chapman, P. B.
Article Title: T-cell chauvinists versus antibody advocates - Can't we all just get along?
Keywords: signal transduction; vasculotropin; bevacizumab; nonhuman; antineoplastic agents; note; rituximab; antineoplastic agent; neoplasm; neoplasms; t lymphocyte; t-lymphocytes; cancer immunotherapy; melanoma; breast cancer; epidermal growth factor receptor; epidermal growth factor receptor 2; editorial; cytotoxicity; cetuximab; cancer research; monoclonal antibody; lung metastasis; b cell lymphoma; cd20 antigen; immunology; antibodies, monoclonal; nonhodgkin lymphoma; cellular immunity; immunotherapy; antigen specificity; ganglioside gd2; colon cancer; fc receptor; trastuzumab; tyrosinase related protein 1; ganglioside gd3; ganglioside gm2; phagocyte; dna polymorphism; immunization; antibody conjugate; immunoconjugates; humans; human; priority journal; monoclonal antibody r24
Journal Title: Journal of Clinical Oncology
Volume: 22
Issue: 22
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2004-11-15
Start Page: 4446
End Page: 4448
Language: English
DOI: 10.1200/jco.2004.06.939
PUBMED: 15483013
PROVIDER: scopus
DOI/URL:
Notes: Cited By (since 1996):3 -- Export Date: 16 June 2014 -- CODEN: JCOND -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Chapman
    326 Chapman